Taken together, the in vivo and in vitro experiments suggested that inhibition of COX-2 is sufficient to damage megakaryopoiesis and thrombopoiesis in ITP and could be the pathogenic factor of ITP. Here, PTGS2 is linked to autoimmune thrombocytopenic purpura.